The Lancet: From Hiroshima and Nagasaki to Fukushima -- Series highlights long-term psychological impact of nuclear disasters

July 30, 2015

On the 70th anniversary of the atomic bombs in Hiroshima and Nagasaki, a three-part Series published in The Lancet looks at the enduring radiological and psychological impact of nuclear disasters, including the most recent accident at the Fukushima Daiichi nuclear power plant in Japan in 2011. The Series provides vital information for the public health planning of future disasters to protect the millions of people who live in areas surrounding the 437 nuclear power plants that are in operation worldwide.

Although nuclear power plant accidents are uncommon, during the past 60 years, five severe nuclear accidents rated as level 5 or higher [1] have taken place--Kyshtym (Russia, 1957), Windscale Piles (UK, 1957), Three Mile Island (USA, 1979), Chernobyl (Russia, 1986), and Fukushima (Japan, 2011).

In one of the Series papers [Paper 2], radiological protection experts led by Dr Koichi Tanigawa of Fukushima Medical University, Japan, discuss an often overlooked aspect of nuclear disasters--the psychological burden of those living in the regions affected by the accident. In 2006, the UN Chernobyl Forum report concluded that the accident's most serious public health issue was the adverse effects on mental health, an effect made worse by poor communication about the health risks associated with reported radiation levels. Rates of depression and post-traumatic stress disorder remain elevated 20 years after the accident. Similar problems were seen after Fukushima, with the Fukushima Health Management Survey reporting that the proportion of adults with psychological distress (14.6%) was almost five times higher among disaster evacuees compared to the general population (3%) [2]. The authors also highlight how repeated evacuation and long-term displacement resulted in severe health-care problems for the most vulnerable, with deaths among elderly people increasing threefold in the first three months following evacuation.

According to Dr Tanigawa, "Although the radiation dose to the public from Fukushima was relatively low, and no discernible physical health effects are expected, psychological and social problems, largely stemming from the differences in risk perceptions, have had a devastating impact on people's lives." [3]

The Fukushima accident resulted in the evacuation of 170000 residents within a 30km radius of the power plant, yet at least one-third of the world's 437 nuclear power plants have more people living within that radius--21 of these sites have more than 1 million people and six have more than 3 million people (eg, Taiwan's Kuosheng plant has 5.5 million people).

In another Series paper [Paper 3], Professor Akira Ohtsuru of Fukushima Medical University, Japan, and colleagues discuss what can be done to protect the millions of residents who might be exposed to radiation in the aftermath of another nuclear accident, and how to minimize potential harms to their physical and mental health. Examples include responding to parental concerns about cancer risks for children and helping evacuees' adjust to new places.

According to the authors, lessons from Fukushima need to be learned. "One of the key tasks of the health services is to reliably communicate that in most nuclear accidents very few people are exposed to a life-threatening dose of radiation. Physicians must play a key role in helping residents' understand the health risks. Evacuation of a large population of vulnerable people in nursing homes and hospitals will also need careful planning and adequate medical support. Additionally, screening for mental illness in residents relocated from their homes and providing mental health care will be essential." [3]

In another Series paper [Paper 1], researchers led by Professor Kenji Kamiya, Vice President of Hiroshima University, Japan, report on the long-term health impact of radiation exposure from the two biggest nuclear disasters in history--the atomic bombings of Hiroshima and Nagasaki and from the Chernobyl nuclear accident in Ukraine in 1986.

Evidence from the Japanese Life Span Study that followed 94000 atomic bomb survivors from 1950, 5 years after the bombings to the current day, reveals a clear increased lifetime risk of cancer in survivors. The risk was found to be proportional to dose for solid cancers, and a higher risk was found in those exposed as children or young adults. After Chernobyl, an increased risk of childhood thyroid cancer among those with internal exposures from consuming radioactivity in food was also seen in affected areas. Hereditary effects in the children of survivors have not yet been detected.

The authors present critical evidence that cancer risk increases significantly after exposure to moderate and high doses of radiation (upwards of 0.1-0.2Gy [4]), but it remains unclear whether risk is increased at lower doses (0.1Gy or less). Given the unknown effects at lower doses, they conclude that, "Ongoing research is vital not only to understand the potential health effects of nuclear disasters, but to develop radiation protection limits and standards for occupational and medical exposures." [3]
-end-
NOTES TO EDITORS:

[1] The international nuclear and radiological event scale classifies level 5 as "an accident with wider consequences" http://www.iaea.org/sites/default/files/ines.pdf

[2] http://www.who.int/bulletin/online_first/BLT.14.146498.pdf

[3] Quotes direct from authors and cannot be found in text of papers.

[4] A gray (Gy) is a unit of absorbed radiation.

The Lancet

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.